Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26874885

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2016 Apr 16
First author
Schöffski P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Apr 16;387(10028):1594-6. doi: 10.1016/S0140-6736(16)00162-8.
    note
    Source null
    related pmid
    26874886
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2016 Apr;13(4):204. doi: 10.1038/nrclinonc.2016.33.
    note
    Source null
    related pmid
    26925959
    relationship
    Comment in

Authors and identifiers

  1. name
    Schöffski P
    type
    Author
  2. name
    Chawla S
    type
    Author
  3. name
    Maki RG
    type
    Author
  4. name
    Italiano A
    type
    Author
  5. name
    Gelderblom H
    type
    Author
  6. name
    Choy E
    type
    Author
  7. name
    Grignani G
    type
    Author
  8. name
    Camargo V
    type
    Author
  9. name
    Bauer S
    type
    Author
  10. name
    Rha SY
    type
    Author
  11. name
    Blay JY
    type
    Author
  12. name
    Hohenberger P
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Schöffski P
    type
    Author
  2. name
    Chawla S
    type
    Author
  3. name
    Maki RG
    type
    Author
  4. name
    Italiano A
    type
    Author
  5. name
    Gelderblom H
    type
    Author
  6. name
    Choy E
    type
    Author
  7. name
    Grignani G
    type
    Author
  8. name
    Camargo V
    type
    Author
  9. name
    Bauer S
    type
    Author
  10. name
    Rha SY
    type
    Author
  11. name
    Blay JY
    type
    Author
  12. name
    Hohenberger P
    type
    Author
bibliography ids
  1. nci-bib-5644b07ac6b02a96f76df0b3
book metadata
content sha256
865afc195a0f8dfd23e8db9c11aeadfcb92399d665821028401697179b31d7e8
document type
citation
dois
  1. 10.1016/S0140-6736(15)01283-0
electronic publication date
display
2016 Feb 10
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:26874885
immutable id
pubmed:26874885@865afc195a0f8dfd23e8db9c11aeadfcb92399d665821028401697179b31d7e8
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10028
name
Lancet (London, England)
nlm unique id
2985213R
pages
1629-37
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Apr 16;387(10028):1594-6. doi: 10.1016/S0140-6736(16)00162-8.
    note
    Source null
    related pmid
    26874886
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2016 Apr;13(4):204. doi: 10.1038/nrclinonc.2016.33.
    note
    Source null
    related pmid
    26925959
    relationship
    Comment in
outcomes validated
false
pmid
26874885
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
759b60e85f185862c6e16d540f5a67a6691bae88aa98326d54382d0831bec8d1
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2016 Apr 16
precision
day
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26874885/
title
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.

Preserved source evidence · Not medical advice